Education
About Us
Working with TipRanks
Follow Us
Omega Diagnostics (GB:CNSL)
:CNSL
CNSL Stock Chart & Stats
Day’s Range― - ―
52-Week Range2.42p - 4.38p
Previous CloseN/A
Volume6.91K
Average Volume (3M)277.30K
Market Cap
£8.33M
Enterprise Value4.36M
Total Cash (Recent Filing)£4.52M
Total Debt (Recent Filing)£79.00K
Price to Earnings (P/E)50.0
Beta0.96
Next Earnings
Aug 19, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding237,950,650
10 Day Avg. Volume304,936
30 Day Avg. Volume277,302
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Omega Diagnostics News
CNSL FAQ
What was Omega Diagnostics’s price range in the past 12 months?
Omega Diagnostics lowest share price was 2.42p and its highest was 4.38p in the past 12 months.
What is Omega Diagnostics’s market cap?
Omega Diagnostics’s market cap is £8.33M.
When is Omega Diagnostics’s upcoming earnings report date?
Omega Diagnostics’s upcoming earnings report date is Aug 19, 2025 which is in 11 days.
How were Omega Diagnostics’s earnings last quarter?
Omega Diagnostics released its earnings results on Nov 21, 2024. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
Is Omega Diagnostics overvalued?
According to Wall Street analysts Omega Diagnostics’s price is currently Overvalued.
Does Omega Diagnostics pay dividends?
Omega Diagnostics does not currently pay dividends.
What is Omega Diagnostics’s EPS estimate?
Omega Diagnostics’s EPS estimate is >-0.01.
How many shares outstanding does Omega Diagnostics have?
Omega Diagnostics has 237,950,650 shares outstanding.
What happened to Omega Diagnostics’s price movement after its last earnings report?
Omega Diagnostics reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of Omega Diagnostics?
Currently, no hedge funds are holding shares in GB:CNSL
Company Description
Omega Diagnostics
Cambridge Nutritional Sciences plc, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the Foodprint name. It provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The company serves government, private hospitals, reference laboratories, nutritionists, naturopaths, and other healthcare professionals. Cambridge Nutritional Sciences plc operates in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc was founded in 1987 and is based in London, the United Kingdom.
Technical Analysis
RUA Life Sciences
―
EKF Diagnostics Holdings
―
Feedback
―
Cizzle Biotechnology Holdings PLC
―
Tristel
―
Ownership Overview
0.08% Insiders
―
Mutual Funds
― Other Institutional Investors
99.92% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---